The underlying causes of erythrocytosis (high hemoglobin/hematoctrit) have been progressively elucidated in recent years. The identification of the underlying causes has assumed greater importance with the identification of the JAK2 V617 mutation found in polycythemia vera and other myeloproliferative neoplasms.
James Hoyer, M.D.
Consultant, Hematopathology
Professor of Laboratory Medicine and Pathology
Mayo Clinic College of Medicine and Science
Co-Director, Metabolic Hematology Laboratory
Mayo Clinic
This webinar is designed for health care professionals who treat patients with hereditary erythrocytosis, including hematopathologists, hematologists, physician assistants, nurse practitioners, and genetic counselors.
Intermediate
Course director(s), planning committee, faculty, and all others who are in a position to control the content of this educational activity are required to disclose all relevant financial relationships with any commercial interest related to the subject matter of the educational activity. Safeguards against commercial bias have been put in place. Faculty members also will disclose any off-label and/or investigational use of pharmaceuticals or instruments discussed in their presentations. Disclosure of this information will be published in course materials so those participants in the activity may formulate their own judgments regarding the presentations.
Mayo Medical Laboratories is not an applicable manufacturer or applicable group purchasing organization (GPO). (GPOs, per the Centers for Medicare & Medicaid Services, and this program do not trigger any reporting requirements pursuant to Open Payments [Sunshine Act] legislation.)
Note: Credit is not offered for this Specialty Testing webinar.
Learn more about our testing